Skip to main content

Table 2 Liver function changes 7 days after first TACE procedure for the two groups

From: Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus

 

DEB-TACE group

C-TACE group

 

Baseline

After

P-Value

Baseline

After

P-Value

AST

85.7 ± 53.1

156.1 ± 142.3

 < 0.001

78.6 ± 45.1

409.3 ± 516.5

 < 0.001

ALT

56.3 ± 31.4

134.6 ± 112.7

0.004

58.7 ± 26.0

341.5 ± 443.9

 < 0.001

TBILI

19.1 ± 13.1

25.8 ± 21.6

0.090

20.1 ± 12.7

38.4 ± 28.7

 < 0.001

ALB

37.6 ± 4.8

34.9 ± 3.9

0.006

37.2 ± 6.8

32.8 ± 4.1

0.001

PT-sec

14.3 ± 1.0

14.4 ± 1.1

0.718

14.5 ± 1.1

15.4 ± 1.3

0.001

  1. AST Aspartate aminotransferase, ALT Alanine aminotransferase, TBILI Total bilirubin, ALB Albumin, PT Prothrombin time
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us